Molecular neurodegeneration.

ISSN 1750-1326BioMed Central LtdUnited Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJJIFMatched via identifier

Journal overview

Journal identity
Titles
Molecular Neurodegeneration
Mol. Neurodegeneration (abbreviated)
Mol Neurodegener (abbreviated)
Molecular neurodegeneration.
Key identifiers
ISSN
Not available
eISSN
1750-1326
NLM ID
101266600
Publisher / basic metadata
Publisher
BioMed Central Ltd
BMC
[London] : BioMed Central, 2006-
Country
Language
ENG
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2006–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

MetricYearValueQuartileRankSource
JIF202517.5Q1200JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
6.262
Best Quartile
Q1
H-index
139
Subject categories
  • Cellular and Molecular Neuroscience — Q1
  • Molecular Biology — Q1
  • Neurology (clinical) — Q1
More metrics
Coverage
2006–2026
Country
United Kingdom
Region
Western Europe
Publisher
BioMed Central Ltd
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
122
Total documents (3 years)
263
Total references
17784
Total citations (3 years)
4453
Citable documents (3 years)
242
Citations per document (2 years)
14.84
References per document
145.77
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
1750-1326
SCImago Source ID
5700191214
SCImago Rank (across all SCImago source types)
196

Publication activity

Publication activity
SCImago
2025
122 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC0
APC (article processing charge)
2990 EUR; 3190 USD; 2590 GBP
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
Yes
Preservation services
CLOCKSS, LOCKSS, PMC, Portico
Added to DOAJ
2007-01-10
Journal homepage
DOAJ profile
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
1750-1326

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Neurobiology; Neurodegenerative Diseases/genetics*Neurodegenerative Diseases/immunology*Neurodegenerative Diseases/therapy
Coverage / history
Scopus:2006-2026
MEDLINE:MEDLINE: v6, Jan. 2011-In: PubMed: v1, 2006-, PMC;
PubMed:MEDLINE: v6, Jan. 2011-In: PubMed: v1, 2006-, PMC;
PMC:v.1 2006 – v.21 2026